HMGB1 and ovarian cancer: In this study, concentrations of the immunogenic biomarkers HMGB1, sRAGE, PD1 and PD-L1 were determined in the blood samples of 231 women with ovarian cancer, inflammation, cysts, other benign diseases or without any diagnosed severe disease.